Literature DB >> 8626727

Selective G protein coupling by C-C chemokine receptors.

Y Kuang1, Y Wu, H Jiang, D Wu.   

Abstract

The C-C chemokines are major mediators of chemotaxis of monocytes and some T cells in inflammatory reactions. The pathways by which the C-C chemokine receptors activate phospholipase C (PLC) were investigated in cotransfected COS-7 cells. The C-C chemokine receptor-1 (CKR-1), the MCP-1 receptor-A (MCP-1Ra), and MCP-1Rb can reconstitute ligand-induced accumulation of inositol phosphates with PLC beta2 in a pertussis toxin-sensitive manner, presumably through G beta gamma released from the Gi proteins. However, these three receptors demonstrated different specificity in coupling to the alpha subunits of the Gq class. While none of the receptors can couple to Galphaq/11, MCP-1Rb can couple to both Galpha14 and Galpha16, but its splicing variant, MCP-1Rb, cannot. Since MCP-1Ra and -b differ only in their C-terminal intracellular domains, the C-terminal ends of MCP-1Rs determine G protein coupling specificity. CKR-1 can couple to Galpha14 but not to Galpha16, suggesting some of the C-C chemokine receptors, unlike the C-X-C chemokine receptors, discriminate against Galpha16, a hematopoietic-specific Galpha subunit. The intriguing specificity in coupling of the Gq class of G proteins implies that the chemokines may be involved in some distinct functions in vivo. The commonality of the chemokine receptors in coupling to the Gi-Gbetagamma-PLC beta2 pathway provides a potential target for developing broad spectrum anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626727     DOI: 10.1074/jbc.271.8.3975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.

Authors:  M K Ho; L Y Yung; J S Chan; J H Chan; C S Wong; Y H Wong
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice.

Authors:  I Davignon; M D Catalina; D Smith; J Montgomery; J Swantek; J Croy; M Siegelman; T M Wilkie
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors.

Authors:  J K Scott; S F Huang; B P Gangadhar; G M Samoriski; P Clapp; R A Gross; R Taussig; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 4.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 5.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 6.  Slit proteins, potential endogenous modulators of inflammation.

Authors:  Necat Havlioglu; Liya Yuan; Hao Tang; Jane Y Wu
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

7.  Roles of phospholipase C beta2 in chemoattractant-elicited responses.

Authors:  H Jiang; Y Kuang; Y Wu; W Xie; M I Simon; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

8.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 9.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 10.  Chemokine signaling in cancer: one hump or two?

Authors:  Joshua B Rubin
Journal:  Semin Cancer Biol       Date:  2008-10-17       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.